# OnCo record nct04042701 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04042701/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04042701", "NCT04042701" ;
  schema:name "Trastuzumab deruxtecan with pembrolizumab"@en ;
  schema:alternateName "DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer"@en ;
  schema:description "This early study combines trastuzumab deruxtecan with pembrolizumab in advanced breast or lung cancer. It studies a suitable dose, side effects and tumor response."@en ;
  schema:url <https://onco.cc/trials/nct04042701/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04042701>, <https://clinicaltrials.ucsf.edu/trial/NCT04042701> ;
  onco:status "active" ;
  onco:tag "ucsf-breast-coverage", "interventional" ;
  onco:phase "1" ;
  schema:startDate "2020-02-10" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/> ;
  onco:institutions <https://onco.cc/institutions/ucsf/> .
